Galectin-3-induced oxidized low-density lipoprotein promotes the phenotypic transformation of vascular smooth muscle cells

Molecular Medicine Reports

Volumn 12, Issue 4, 2015, Pages 4995-5002

  Tian, Lei ^a   Chen, Kan ^a   Cao, Jiatian ^a   Han, Zhihua ^a   Gao, Lin ^a   Wang, Yue ^a   Fan, Yuqi ^a   Wang, Changqian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Galectin 3; Oxidized low density lipoprotein; Phenotypic transformation; Vascular smooth muscle cell; Wnt catenin signaling

Indexed keywords

ALPHA ACTIN; BETA CATENIN; CALPONIN; CONTRACTILE PROTEIN; GALECTIN 3; OSTEOPONTIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SMALL INTERFERING RNA; SMOOTH MUSCLE CONTRACTILE PROTEIN; UNCLASSIFIED DRUG; ACTIN; ACTIN BINDING PROTEIN; CALCIUM BINDING PROTEIN; CTNNB1 PROTEIN, HUMAN; GALECTIN-3, HUMAN; LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; CELL MIGRATION; CELL PHAGOCYTOSIS; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; INVESTIGATIVE PROCEDURES; PHENOTYPE; PHENOTYPIC TRANSFORMATION; PRIMARY CULTURE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; VASCULAR SMOOTH MUSCLE CELL; ANTAGONISTS AND INHIBITORS; CELL DIFFERENTIATION; CELL MOTION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHAGOCYTOSIS; PRIMARY CELL CULTURE; SMOOTH MUSCLE CELL; UMBILICAL CORD; VASCULAR SMOOTH MUSCLE; WNT SIGNALING PATHWAY;

ACTINS; BETA CATENIN; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GALECTIN 3; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS, LDL; MICROFILAMENT PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOPONTIN; PHAGOCYTOSIS; PHENOTYPE; PRIMARY CELL CULTURE; RNA, SMALL INTERFERING; UMBILICAL CORD; WNT SIGNALING PATHWAY;

EID: 84940524840     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4075     Document Type: Article

References (39)

1. Mill C and George SJ: Wnt signalling in smooth muscle cells and its role in cardiovascular disorders. Cardiovasc Res 95: 233-240, 2012.
2. Rensen SS, Doevendans PA and van Eys GJ: Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 15: 100-108, 2007.
3. Dumic J, Dabelic S and Flögel M: Galectin-3: An open-ended story. Biochim Biophys Acta 1760: 616-635, 2006.
4. Markowska AI, Liu FT and Panjwani N: Galectin-3 is an important mediator of VEGF-and bFGF-mediated angiogenic response. J Exp Med 207: 1981-1993, 2010.
5. Anand IS, Rector TS, Kuskowski M, Adourian A, Muntendam P and Cohn JN: Baseline and serial measurements of galectin-3 in patients with heart failure: Relationship to prognosis and effect of treatment with valsartan in the Val-HeFT. Eur J Heart Fail 15: 511-518, 2013.
6. Calvier L, Miana M, Reboul P, Cachofeiro V, Martinez-Martinez E, de Boer RA, Poirier F, Lacolley P, Zannad F, Rossignol P, and López-Andrés N: Galectin-3 mediates aldosterone-induced vascular fbrosis. Arterioscler Thromb Vasc Biol 33: 67-75, 2013.
7. Morrow DA and O'Donoghue ML: Galectin-3 in cardiovascular disease: A possible window into early myocardial fbrosis. J Am Coll Cardiol 60: 1257-1258, 2012.
8. Wesley U V, Vemuganti R, Ayvaci ER and Dempsey RJ: Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling. Brain Res 1496: 1-9, 2013.
9. Arar C, Gaudin JC, Capron L and Legrand A: Galectin-3 gene (LGALS3) expression in experimental atherosclerosis and cultured smooth muscle cells. FEBS Lett 430: 307-311, 1998.
10. Massaeli H, Hurtado C, Austria JA and Pierce GN: Oxidized low-density lipoprotein induces cytoskeletal disorganization in smooth muscle cells. Am J Physiol 277: H2017-H2025, 1999.
11. Obradovic MM, Trpkovic A, Bajic V, Soskic S, Jovanovic A, Stanimirovic J, Panic M and Isenovic ER: Interrelatedness between C-reactive protein and oxidized low-density lipoprotein. Clin Chem Lab Med 53: 29-34, 2015.
12. Steinberg D: Oxidized low density lipoprotein-an extreme example of lipoprotein heterogeneity. Isr J Med Sci 32: 469-472, 1996.
13. Auge N, Garcia V, Maupas-Schwalm F, Levade T, Salvayre R and Negre-Salvayre A: Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arterioscler Thromb Vasc Biol 22: 1990-1995, 2002.
14. Leavesley DI, Schwartz MA, Rosenfeld M and Cheresh DA: Integrin beta 1-and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 121: 163-170, 1993.
15. Argmann CA, Sawyez CG, Li S, Nong Z, Hegele RA, Pickering JG and Huff MW: Human smooth muscle cell subpopulations differentially accumulate cholesteryl ester when exposed to native and oxidized lipoproteins. Arterioscler Thromb Vasc Biol 24: 1290-1296, 2004.
16. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
17. Karagiannis GS, Weile J, Bader GD and Minta J: Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation. BMC Cardiovasc Disord 13: 4, 2013.
18. Augé N, Maupas-Schwalm F, Elbaz M, Thiers JC, Waysbort A, Itohara S, Krell HW, Salvayre R and Nègre-Salvayre A: Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingo-myelin/ceramide pathway and smooth muscle cell proliferation. Circulation 110: 571-578, 2004.
19. Guyton JR, Lenz ML, Mathews B, Hughes H, Karsan D, Selinger E and Smith CV: Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants. Atherosclerosis 118: 237-249, 1995
20. Deng DX, Spin JM, Tsalenko A, Vailaya A, Ben-Dor A, Yakhini Z, Tsao P, Bruhn L and Quertermous T: Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: Distinct responses to stimuli. Arterioscler Thromb Vasc Biol 26: 1058-1065, 2006.
21. Ding Z, Liu S, Yang B, Fan Y and Deng X: Effect of oxidized low-density lipoprotein concentration polarization on human smooth muscle cells' proliferation, cycle, apoptosis and oxidized low-density lipoprotein uptake. J R Soc Interface 9: 1233-1240, 2012.
22. Shimura T, Takenaka Y, Tsutsumi S, Hogan V, Kikuchi A and Raz A: Galectin-3, a novel binding partner of beta-catenin. Cancer Res 64: 6363-6367, 2004.
23. Menini S, Iacobini C, Ricci C, Blasetti Fantauzzi C, Salvi L, Pesce CM, Relucenti M, Familiari G, Taurino M and Pugliese G: The galectin-3/RAGE dyad modulates vascular osteogenesis in athero-sclerosis. Cardiovasc Res 100: 472-480, 2013.
24. Kim K, Mayer EP and Nachtigal M: Galectin-3 expression in macrophages is signaled by Ras/MAP kinase pathway and up-regulated by modified lipoproteins. Biochim Biophys Acta 1641: 13-23, 2003.
25. Liu J, Ren Y, Kang L and Zhang L Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin. Int J Mol Med 33: 1341-1347, 2014.
26. Dzau VJ, Braun-Dullaeus RC and Sedding DG: Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies. Nat Med 8: 1249-1256, 2002.
27. Nachtigal M, Ghaffar A and Mayer EP: Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-defcient mice. Am J Pathol 172: 247-255, 2008.
28. Xue JH, Yuan Z, Wu Y, Liu Y, Zhao Y, Zhang WP, Tian YL, Liu WM, Liu Y and Kishimoto C: High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance. Cardiovasc Res 86: 141-150, 2010.
29. Rong JX, Shapiro M, Trogan E and Fisher EA: Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Natl Acad Sci USA 100: 13531-13536, 2003.
30. Carthy JM, Luo Z and McManus BM: WNT3A induces a contractile and secretory phenotype in cultured vascular smooth muscle cells that is associated with increased gap junction communication. Lab Invest 92: 246-255, 2012.
31. Hao H, Gabbiani G and Bochaton-Piallat ML: Arterial smooth muscle cell heterogeneity: Implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 23: 1510-1520, 2003.
32. Rama A, Matsushita T, Charolidi N, Rothery S, Dupont E and Severs NJ: Up-regulation of connexin43 correlates with increased synthetic activity and enhanced contractile differentiation in TGF-β-treated human aortic smooth muscle cells. Eur J Cell Biol 85: 375-386, 2006.
33. Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW and Koeffer HP: Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res 64: 1987-1996, 2004.
34. Lee KB, Ye S, Park MH, Park BH, Lee JS and Kim SM: p63-Mediated activation of the β-catenin/c-Myc signaling pathway stimulates esophageal squamous carcinoma cell invasion and metastasis. Cancer Lett 353: 124-132, 2014
35. Kim SJ, Choi I J, Cheong TC, Lee SJ, Lotan R, Park SH and Chun KH: Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression. Gastroenterology 138: 1035-1045, 2010.
36. Kobayashi T, Shimura T, Yajima T, Kubo N, Araki K, Tsutsumi S, Suzuki H, Kuwano H and Raz A: Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin. Int J Cancer 129: 2775-2786, 2011.
37. Zhang D, Chen ZG, Liu SH, Dong ZQ, Dalin M, Bao SS, Hu YW and Wei FC: Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregu-lating β-catenin. Acta Pharmacol Sin 34: 176-184, 2013.
38. Song S, Mazurek N, Liu C, Sun Y, Ding QQ, Liu K, Hung MC and Bresalier RS: Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity. Cancer Res 69: 1343-1349, 2009
39. Weir RA, Petrie CJ, Murphy CA, Clements S, Steedman T, Miller AM, McInnes IB, Squire IB, Ng LL, Dargie HJ, and McMurray JJ: Galectin-3 and cardiac function in survivors of acute myocardial infarction. Circ Heart Fail 6: 492-498, 2013.